Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05426096 · ClinicalTrials.gov registry record · NA
Comparison of Intraoperative Best Practice Advisory Reminders to Protocolize Insulin Administration Versus Standard Care in Patients at High Risk of Hyperglycemia
A NA study, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 7,232
- Enrollment target
NCT05426096 is a NA study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 7,232 participants.
The verdict
NCT05426096, a NA study, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 7,232 participants
- Enrollment target
Study Summary
This study will assess the implementation of a glucose management clinical decision support tool. The specific objective is to determine if supplementing the existing glucose check reminder with a best practice advisory (BPA), an actionable insulin dosing calculator, providers will be influenced to improve the control of hyperglycemia.
Interventions
- OTHER Best Practice Advisory
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,232 participants |
| Start Date | 2022-10-05 |
| Est. Completion | 2023-10-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05426096
The ClinicalTrials.gov registry entry for NCT05426096 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7,232 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Best Practice Advisory is the first listed.
NCT05426096 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05426096 about?
NCT05426096 is a clinical study titled "Comparison of Intraoperative Best Practice Advisory Reminders to Protocolize Insulin Administration Versus Standard Care in Patients at High Risk of Hyperglycemia". This study will assess the implementation of a glucose management clinical decision support tool. The specific objective is to determine if supplementing the existing glucose check reminder with a best practice advisory (BPA), an actionable insulin dosing calculator, providers will be influenced to ...
What is the current status of trial NCT05426096?
This trial is currently completed. It is a NA study. The enrollment target is 7,232 participants. The study started on 2022-10-05. Estimated completion is 2023-10-05.
What interventions are being tested in trial NCT05426096?
The interventions under investigation include: Best Practice Advisory (OTHER).
Who is sponsoring clinical trial NCT05426096?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.